CLINICAL_TRIALS
trial_result
· 2025-11-17
Clinical Trial Update: XG005 for Pain Control in Subjects Undergoing Bunionectomy [Phase 2, Phase 3]
Summary
XG005's Phase 2 and Phase 3 trials for postoperative acute pain after bunionectomy have completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xgene Pharmaceutical Group | Conditions: Acute Pain | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-11-17